Novo Nordisk A S (NVO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $39.22, +2.89% vs the prior close of $38.12.
- Volume 14.77M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NVO rises 2.9% to $39.22. Closed at $39.22, +2.89% vs the prior close of $38.12. Day range $38.89–$39.68, opened at $38.99.
NVO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NVO rises 2.9% to $39.22
- Closed at $39.22, +2.89% vs the prior close of $38.12. Day range $38.89–$39.68, opened at $38.99.
- Volume was 14.77M shares, 1.2x its 50-day average of 12.68M.
- Price is -8.5% vs its 50-day average ($42.85) and -13.1% vs its 200-day average ($45.13).
- 52-week range $35.12–$64.16; today's close sits at 14% of that range, 38.9% below the 52-week high.
Oct 14, 2026 — NVO ends flat (+0.2%) to $38.12
- Closed at $38.12, +0.16% vs the prior close of $38.06. Day range $37.90–$38.42, opened at $37.91.
- Volume was 9.36M shares, 0.7x its 50-day average of 13.44M.
- Price is -11.3% vs its 50-day average ($42.96) and -15.6% vs its 200-day average ($45.19).
- 52-week range $35.12–$64.16; today's close sits at 10% of that range, 40.6% below the 52-week high.
Oct 13, 2026 — NVO dips 1.3% to $38.06
- Closed at $38.06, -1.35% vs the prior close of $38.58. Day range $37.98–$38.89, opened at $38.74.
- Volume was 9.25M shares, 0.7x its 50-day average of 13.49M.
- Price is -11.7% vs its 50-day average ($43.08) and -15.9% vs its 200-day average ($45.26).
- 52-week range $35.12–$64.16; today's close sits at 10% of that range, 40.7% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — NVO ends flat (-0.2%) to $38.58
- Closed at $38.58, -0.16% vs the prior close of $38.64. Day range $38.26–$38.85, opened at $38.85.
- Volume was 8.72M shares, 0.6x its 50-day average of 13.85M.
- Price is -10.8% vs its 50-day average ($43.26) and -14.9% vs its 200-day average ($45.33).
- 52-week range $35.12–$64.16; today's close sits at 12% of that range, 39.9% below the 52-week high.
Oct 9, 2026 — NVO rises 1.2% to $38.64
- Closed at $38.64, +1.20% vs the prior close of $38.18. Day range $38.06–$38.68, opened at $38.11.
- Volume was 9.65M shares, 0.7x its 50-day average of 13.87M.
- Price is -11.0% vs its 50-day average ($43.43) and -14.9% vs its 200-day average ($45.40).
- 52-week range $35.12–$64.16; today's close sits at 12% of that range, 39.8% below the 52-week high.
Oct 8, 2026 — NVO ends flat (-0.2%) to $38.18
- Closed at $38.18, -0.21% vs the prior close of $38.26. Day range $37.51–$38.23, opened at $37.80.
- Volume was 11.81M shares, 0.9x its 50-day average of 13.81M.
- Price is -12.6% vs its 50-day average ($43.69) and -16.0% vs its 200-day average ($45.45).
- 52-week range $35.12–$64.16; today's close sits at 11% of that range, 40.5% below the 52-week high.
Oct 7, 2026 — NVO rises 1.9% to $38.26
- Closed at $38.26, +1.95% vs the prior close of $37.53. Day range $37.51–$38.47, opened at $37.57.
- Volume was 13.67M shares, 1.0x its 50-day average of 13.73M.
- Price is -13.0% vs its 50-day average ($43.96) and -15.9% vs its 200-day average ($45.50).
- 52-week range $35.12–$64.16; today's close sits at 11% of that range, 40.4% below the 52-week high.
Oct 6, 2026 — NVO ends flat (-0.0%) to $37.53
- Closed at $37.53, -0.03% vs the prior close of $37.54. Day range $36.85–$37.53, opened at $37.35.
- Volume was 13.70M shares, 1.0x its 50-day average of 13.59M.
- Price is -15.1% vs its 50-day average ($44.21) and -17.6% vs its 200-day average ($45.54).
- 52-week range $35.12–$64.16; today's close sits at 8% of that range, 41.5% below the 52-week high.
- SEC filings that day: 6-K.
Oct 5, 2026 — NVO rises 0.6% to $37.54
- Closed at $37.54, +0.59% vs the prior close of $37.32. Day range $36.86–$37.61, opened at $36.94.
- Volume was 18.70M shares, 1.4x its 50-day average of 13.43M.
- Price is -15.6% vs its 50-day average ($44.45) and -17.7% vs its 200-day average ($45.59).
- 52-week range $35.12–$64.16; today's close sits at 8% of that range, 41.5% below the 52-week high.
- SEC filings that day: 6-K.
Oct 2, 2026 — NVO ends flat (-0.2%) to $37.32, a 3-month low, 5 down days in a row
- Closed at $37.32, -0.21% vs the prior close of $37.40. Day range $37.17–$37.65, opened at $37.64.
- Volume was 10.26M shares, 0.8x its 50-day average of 13.39M.
- Price is -16.5% vs its 50-day average ($44.68) and -18.2% vs its 200-day average ($45.65).
- 52-week range $35.12–$64.16; today's close sits at 8% of that range, 41.8% below the 52-week high.
- That makes 5 straight losses.
NVO latest news & SEC filings
Every SEC filing by or about NVO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 6, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 5, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 28, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 21, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 15, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 31, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 24, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 10, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 10, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 4, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 4, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade NVO
- How much it moves: over the last 20 sessions the average daily move was 1.31% (largest 8.0%).
- Liquidity: about 15.38M shares (≈$603.31M) trade per day on average.
- 52-week position: $39.22 vs a range of $35.12–$64.16 (14% of the range).
- Dividends: last ex-dividend date Aug 17, 2026 ($0.579/share); 2 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 13, 2026; 6-K Oct 6, 2026; 6-K Oct 5, 2026.
- Listing: NYSE · industry: Pharmaceutical Preparations.
NVO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 38.99 | 39.68 | 38.89 | 39.22 | 14.77M |
| Oct 14, 2026 | 37.91 | 38.42 | 37.90 | 38.12 | 9.36M |
| Oct 13, 2026 | 38.74 | 38.89 | 37.98 | 38.06 | 9.25M |
| Oct 12, 2026 | 38.85 | 38.85 | 38.26 | 38.58 | 8.72M |
| Oct 9, 2026 | 38.11 | 38.68 | 38.06 | 38.64 | 9.65M |
| Oct 8, 2026 | 37.80 | 38.23 | 37.51 | 38.18 | 11.81M |
| Oct 7, 2026 | 37.57 | 38.47 | 37.51 | 38.26 | 13.67M |
| Oct 6, 2026 | 37.35 | 37.53 | 36.85 | 37.53 | 13.70M |
| Oct 5, 2026 | 36.94 | 37.61 | 36.86 | 37.54 | 18.70M |
| Oct 2, 2026 | 37.64 | 37.65 | 37.17 | 37.32 | 10.26M |
| Oct 1, 2026 | 37.80 | 37.97 | 37.37 | 37.40 | 12.66M |
| Sep 30, 2026 | 38.05 | 38.77 | 37.89 | 37.91 | 21.56M |
| Sep 29, 2026 | 38.21 | 38.38 | 38.05 | 38.31 | 9.40M |
| Sep 28, 2026 | 38.40 | 38.90 | 38.23 | 38.71 | 11.43M |
| Sep 25, 2026 | 38.81 | 38.83 | 38.41 | 38.80 | 10.06M |
| Sep 24, 2026 | 37.95 | 38.72 | 37.92 | 38.62 | 20.06M |
| Sep 23, 2026 | 38.90 | 39.14 | 38.16 | 38.17 | 18.44M |
| Sep 22, 2026 | 39.50 | 39.89 | 39.11 | 39.40 | 24.46M |
| Sep 21, 2026 | 41.05 | 41.17 | 39.54 | 39.80 | 49.34M |
| Sep 18, 2026 | 43.50 | 43.54 | 42.78 | 43.24 | 10.36M |
About Novo Nordisk A S
Novo Nordisk A S (NVO) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BAGSVAERD DENMARK, Denmark. Fiscal year ends December 31. SEC CIK 353278.
NVO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NVO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
NVO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NVO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.